Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trial
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trial ; volume:11 ; number:1 ; day:15 ; month:2 ; year:2011 ; pages:1-7 ; date:12.2011
BMC cancer ; 11, Heft 1 (15.2.2011), 1-7, 12.2011
- Urheber
-
Blesius, Aurore
- Beteiligte Personen und Organisationen
-
Cassier, Philippe A.
Bertucci, François
Fayette, Jerome
Ray-Coquard, Isabelle
Bui, Binh
Adenis, Antoine
Rios, Maria
Cupissol, Didier
Pérol, David
Blay, Jean-Yves
Le Cesne, Axel
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-11-72
- URN
-
urn:nbn:de:1111-2016030363612
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:29 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Blesius, Aurore
- Cassier, Philippe A.
- Bertucci, François
- Fayette, Jerome
- Ray-Coquard, Isabelle
- Bui, Binh
- Adenis, Antoine
- Rios, Maria
- Cupissol, Didier
- Pérol, David
- Blay, Jean-Yves
- Le Cesne, Axel
- SpringerLink (Online service)
Ähnliche Objekte (12)
Effect of skeletal muscle loss during neoadjuvant imatinib therapy on clinical outcomes in patients with locally advanced GIST
Reintroduction of Imatinib in GIST
Gastrointestinale Stromatumoren (GIST) : Imatinib-Therapieoptionen voll ausschöpfen durch Dosisoptimierung
Treatment of gastrointestinal tumor (GIST) of the rectum requiring abdominoperineal resection following neoadjuvant imatinib: a cost-effectiveness analysis
Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST)
Improved Efficacy of First-Line Imatinib in Advanced Gastrointestinal Stromal Tumors (GIST): The Dutch GIST Registry Data
Molecular modelling evaluation of exon 18 His845_Asn848delinsPro PDGFRα mutation in a metastatic GIST patient responding to imatinib
Regorafenib bei GIST : neuer Therapie-Standard bei Progress nach Imatinib und Sunitinib
Genomic and clinical characterization of a familial GIST kindred intolerant to imatinib
Imatinib-induced liver cirrhosis in a patient with advanced gastrointestinal stroma tumor (GIST)
Inflammation and nutritional status indicators as prognostic indicators for patients with locally advanced gastrointestinal stromal tumors treated with neoadjuvant imatinib
The management of metastatic GIST: current standard and investigational therapeutics
Effect of skeletal muscle loss during neoadjuvant imatinib therapy on clinical outcomes in patients with locally advanced GIST
Reintroduction of Imatinib in GIST
Gastrointestinale Stromatumoren (GIST) : Imatinib-Therapieoptionen voll ausschöpfen durch Dosisoptimierung
Treatment of gastrointestinal tumor (GIST) of the rectum requiring abdominoperineal resection following neoadjuvant imatinib: a cost-effectiveness analysis
Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST)
Improved Efficacy of First-Line Imatinib in Advanced Gastrointestinal Stromal Tumors (GIST): The Dutch GIST Registry Data
Molecular modelling evaluation of exon 18 His845_Asn848delinsPro PDGFRα mutation in a metastatic GIST patient responding to imatinib
Regorafenib bei GIST : neuer Therapie-Standard bei Progress nach Imatinib und Sunitinib
Genomic and clinical characterization of a familial GIST kindred intolerant to imatinib
Imatinib-induced liver cirrhosis in a patient with advanced gastrointestinal stroma tumor (GIST)
Inflammation and nutritional status indicators as prognostic indicators for patients with locally advanced gastrointestinal stromal tumors treated with neoadjuvant imatinib
The management of metastatic GIST: current standard and investigational therapeutics
Effect of skeletal muscle loss during neoadjuvant imatinib therapy on clinical outcomes in patients with locally advanced GIST
Reintroduction of Imatinib in GIST
Gastrointestinale Stromatumoren (GIST) : Imatinib-Therapieoptionen voll ausschöpfen durch Dosisoptimierung
Treatment of gastrointestinal tumor (GIST) of the rectum requiring abdominoperineal resection following neoadjuvant imatinib: a cost-effectiveness analysis
Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST)
Improved Efficacy of First-Line Imatinib in Advanced Gastrointestinal Stromal Tumors (GIST): The Dutch GIST Registry Data
Molecular modelling evaluation of exon 18 His845_Asn848delinsPro PDGFRα mutation in a metastatic GIST patient responding to imatinib
Regorafenib bei GIST : neuer Therapie-Standard bei Progress nach Imatinib und Sunitinib
Genomic and clinical characterization of a familial GIST kindred intolerant to imatinib
Imatinib-induced liver cirrhosis in a patient with advanced gastrointestinal stroma tumor (GIST)
Inflammation and nutritional status indicators as prognostic indicators for patients with locally advanced gastrointestinal stromal tumors treated with neoadjuvant imatinib